De novo glomerular diseases after renal transplantation - Wikidata - awgldk - TriplyDB

De novo glomerular diseases after renal transplantation

De novo glomerular diseases after renal transplantation

http://www.wikidata.org/entity/Q27005877

about

Infection-Related Focal Segmental Glomerulosclerosis in Children Hepatitis C and kidney disease: A narrative review.Permeability factors in focal and segmental glomerulosclerosis.Primary Membranous Nephropathy.Current status of pediatric renal transplant pathology.Targeting mTOR Signaling Can Prevent the Progression of FSGS.Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease.De Novo Focal Segmental Glomerulosclerosis in Renal Allograft-Histological Presentation and Clinical Correlation: Single Centre Experience De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?

P2860

Q26746638-A893B7B8-4450-4AF9-AFC0-802B30809B0F Q30238652-F555A7AF-62B6-4F9E-8464-A700D831B175 Q38244353-77FF7528-3BFB-4934-9874-054D6D9890F0 Q38760741-62C836E0-BB3F-4CCC-B49B-D1B6B91F0356 Q38843499-80C47297-18F3-4D10-9048-B2B5B4A3C303 Q38922365-E274ABDA-EA2D-478D-9CD9-4A39C1AFF8AC Q40441782-AF6EB89B-CB0B-464B-90AF-DAB1861B6640 Q42236892-DB31F029-5F9A-42FC-B618-0949666A42FB Q47172094-3EED547E-7726-4BD2-B25A-3A80814D6C94

P2860

De novo glomerular diseases after renal transplantation

http://www.wikidata.org/entity/Q27005877

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

De novo glomerular diseases after renal transplantation

@ast

De novo glomerular diseases after renal transplantation

@en

De novo glomerular diseases after renal transplantation

@nl

type

label

De novo glomerular diseases after renal transplantation

@ast

De novo glomerular diseases after renal transplantation

@en

De novo glomerular diseases after renal transplantation

@nl

prefLabel

De novo glomerular diseases after renal transplantation

@ast

De novo glomerular diseases after renal transplantation

@en

De novo glomerular diseases after renal transplantation

@nl

P1433

Q27005877-B6EC5490-53F0-4641-8D9D-EC5AF98D6070

P1476

Q27005877-911E4783-482B-4B64-8A92-2ECA16DFEC8D

P2093

Q27005877-3F603A22-ACB0-4C27-9B1A-B3EC9718F657

Q27005877-47092474-A072-4C9D-95AB-AB5C27704AA5

P2860

Q27005877-00DA1461-FF25-4C30-802F-299E491B2276

Q27005877-034EDC6C-8F98-4DE7-8CB8-876B11BD2E93

Q27005877-03A26F2A-3CAC-4977-8838-DDD1A8CC8630

Q27005877-07BF1029-6768-4455-98CF-E5BFB6852D22

Q27005877-097C407A-6361-4A55-AA94-FDE3A12C4CA5

Q27005877-0CAD35D9-6938-43E7-B1E2-03883F333332

Q27005877-150DA9C6-E2AF-44B4-8301-D002780A78E7

Q27005877-155ECAF9-FDE0-4FF3-9D32-60B31814402F

Q27005877-159CFC13-ADBC-4DB2-8AC5-10A84D00CB70

Q27005877-18C99696-8BD7-498F-96F0-8D3B71C9C0DF

P304

Q27005877-0D71DBB1-AD0E-4DF4-9D91-757F4F54692B

P31

Q27005877-975FF7F4-4997-4329-9818-651EFF5C53C4

P3181

Q27005877-C20AE070-0F88-4A6B-A8B8-AE99423A2D50

P356

Q27005877-AFFA2387-1FA1-4D4C-A5E2-D302B17D515F

P407

Q27005877-5F70AE50-DDB1-4DF4-BF6A-243FDB6198CD

P433

Q27005877-04EB3D69-B9AE-497B-9D0B-03A5F6DD41FC

P478

Q27005877-8D7638B6-FAE5-4177-856C-E3E4818F8F9D

P50

Q27005877-6D719C9C-9B10-41CF-8EF2-A4B17F217CF7

P577

Q27005877-59AC75C6-F38D-4061-BC8F-2F26DF6B1E95

P5875

Q27005877-346169E2-7792-442A-BBA1-7D7E3C103A32

P698

Q27005877-A9011328-C959-41F2-ABE1-1D1F22A8DD4A

P932

Q27005877-329AE709-5D96-4D13-80F9-59FF1625611E

P3181

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

De novo glomerular diseases after renal transplantation

@en

P2093

Claudio Ponticelli

http://www.w3.org/2001/XMLSchema#string

Richard J Glassock

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Membranoproliferative glomerulonephritis--a new look at an old entity

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.

Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.

Thrombotic microangiopathy after renal transplantation in the United States.

Thrombotic microangiopathy after kidney transplantation.

De novo thrombotic microangiopathy. An underrated complication of renal transplantation.

P304

1479-1487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1576316

http://www.w3.org/2001/XMLSchema#string

P356

10.2215/CJN.12571213

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Gabriella Moroni

P577

2014-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261374930

http://www.w3.org/2001/XMLSchema#string

P698

24700797

http://www.w3.org/2001/XMLSchema#string

P932

4123406

http://www.w3.org/2001/XMLSchema#string